Google DeepMind has introduced AlphaGenome 2 to predict how DNA variations affect specific human cell types, with access ...

Presentations include interim Phase 3 results in women, integrated outcomes from three Phase 3 dialysis access trials and long-term human explant data. – Podium presentation to provide an update on ...

Francis Medical, Inc., a medical device company dedicated to advancing minimally invasive therapies for urological cancers, ...

Conexeu has launched a human collagen initiative at its Vancouver research and development facility, for its aesthetics program, focused on potential tissue-restoration applications associated with ...

Presentation at plenary session on clinical trials will highlight initial clinical data from ongoing ADCElerate1 trial in patients with advanced soft tissue sarcoma COPENHAGEN, Denmark, Nov. 10, 2026 ...

Controversy over Temple: a temple-worn device claims to monitor brain health via cerebral blood flow, but evidence is ...

Commercial adoption of Symvess® accelerated during the third quarter with sales totaling $1.0 million, a 151% increase over ...

Now, Washington is opening a regulatory path for some of these unproven peptides. On October 28, HHS announced an interim ...

Tissue Repair Ltd (ASX:TRP) share price, share research, charts, announcements, dividends, director trades and news at IntelligentInvestor.com.au ...

A cross-sectional investigation across five Central Cameroon divisions revealed nontyphoidal Salmonella contamination in over ...

For years, success in kidney disease has largely been measured by how much its progression could be slowed. Newer treatments ...

Kimberly-Clark has completed its acquisition of Kenvue, bringing together the two companies’ consumer health and personal ...